GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (FRA:3G6) » Definitions » Other Stockholders Equity

GNI Group (FRA:3G6) Other Stockholders Equity : €30.6 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is GNI Group Other Stockholders Equity?

GNI Group's Other Stockholders Equity for the quarter that ended in Mar. 2024 was €30.6 Mil.

GNI Group's quarterly Other Stockholders Equity declined from Sep. 2023 (€31.1 Mil) to Dec. 2023 (€29.1 Mil) but then increased from Dec. 2023 (€29.1 Mil) to Mar. 2024 (€30.6 Mil).

GNI Group's annual Other Stockholders Equity increased from Dec. 2021 (€11.2 Mil) to Dec. 2022 (€22.0 Mil) and increased from Dec. 2022 (€22.0 Mil) to Dec. 2023 (€29.1 Mil).


GNI Group Other Stockholders Equity Historical Data

The historical data trend for GNI Group's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Other Stockholders Equity Chart

GNI Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -1.99 11.23 22.02 29.10

GNI Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.64 27.94 31.10 29.10 30.62

GNI Group Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


GNI Group Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of GNI Group's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


GNI Group (FRA:3G6) Business Description

Industry
Traded in Other Exchanges
Address
Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (FRA:3G6) Headlines

No Headlines